Belgium· BE-AMP-SAM289983-00

Exjade 500 mg

A deferasirox product containing deferasirox, registered in Belgium by Novartis Europharm. The same ATC class is registered in 18 of our 19 countries.

ATC V03AC03

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about deferasiroxAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Deferasirox is registered in 18 of 19 countries.

Countries holding a registration under ATC V03AC03 (deferasirox), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search deferasirox products by name

Deferasirox · ATC V03AC03

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deferasirox costs, country by country.

Normalised to the WHO defined daily dose (0.98 g), the median price runs from $24.11 in Spain to $59.57 in Switzerland — a ×2.5 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Deferasirox · price per daily dose (0.98 g)

USD · FX 28 Sept 2026

CH Switzerland$59.57
IT Italy$43.21
FR France$27.16
ES Spain$24.11

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Deferasirox
Manufacturer: Novartis Europharm
Country: Belgium (BE)
ATC code: V03AC03
ATC class: Deferasirox
Defined daily dose: 0.98 g, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
2380418
be_apb
0785618

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

616 interactions on record for deferasirox.

Graded by severity as the source publishes them — 205 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check deferasirox against other medicines How interaction checks work

Deferasirox · interactions on record

616 records

205 severe
399 moderate
12 minor

Most severe, free to view

NeomycinA07AA01severe
StreptomycinA07AA04severe
Polymyxin BA07AA05severe
Amphotericin BA07AA07severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deferasirox in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deferasirox products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Deferasirox G.L., Deferasirox Ratiopharm
Bulgaria · Deferasirox Synthon, Ziadex
Cyprus · Deferasirox Msn, Issoferrol
Czechia · Deferasirox Auxpharma, Deferasirox Glenmark
Germany · Deferasi Puren, Deferasirox Abdi
Denmark · Deferasirox Deferasirox "jubilant", Deferasirox Glenmark
Spain · Deferasirox Abdi, Deferasirox Aurovitas
Finland · Deferasirox Glenmark, Deferasirox Stada
France · Deferasirox Arrow, Deferasirox Bgr
United Kingdom (Northern Ireland) · Deferasirox Abdi Farma, Deferasirox Amarox
Greece · Deferasirox Pharmathen, Deferasirox Rafarm
Croatia · Deferasiroks Pliva, Deferasiroks Umedica
Hungary · Deferasirox Msn, Deferasirox Pharmascience
Iceland · Deferasirox Accord, Deferasirox Medical Valley
Italy · Deferasirox Abdi, Deferasirox Aurobindo
Liechtenstein · Deferasirox Accord, Deferasirox Mylan
Latvia · Deferasirox Umedica
Malta · Deferasirox Pharos
Netherlands · Deferasirox Abdi, Deferasirox Amarox
Norway · Deferasirox Accord, Deferasirox Medical Valley
Poland · Deferasirox Msn, Exferana
Portugal · Deferasirox 180 Mg, Deferasirox 360 Mg
Romania · Deferasirox Msn Laboratories, Deferasirox Sanexcel
Sweden · Deferasirox Glenmark, Deferasirox Jubilant
Slovakia · Deferasirox, Deferasirox Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f063c470-5a62-4f10-be7b-da5954e28d61
GET /v1/drugs/f063c470-5a62-4f10-be7b-da5954e28d61?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersible tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Exjade 500 mg",
  "name_fr": "Exjade 500 mg",
  "name_nl": "Exjade 500 mg",
  "amp_code": "SAM289983-00",
  "strengths": [
    "500.0000",
    "500.0000",
    "500.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Deferasirox"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Deferasirox",
  "authorisation_numbers": [
    "EU/1/06/356/005",
    "EU/1/06/356/006",
    "EU/1/06/356/009",
    "EU/1/06/356/010"
  ]
}

API reference MCP server Plans

See everything about deferasirox.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console